{"transactions":[{"id":2943532,"issuer":{"id":8636,"kind":"organization","name":"Mosaic ImmunoEngineering Inc."},"owners":[{"id":144629,"kind":"person","name":"JOHNSON CARLTON M","position":1,"cik":"0001244103","reported_name":"JOHNSON CARLTON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-17T01:17:39.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":26087,"price":3.3,"value":86087.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSU's granted under the Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan for non-employee Board compensation. RSUs will vest 100% on December 16, 2021, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":26087,"derivative":{"exercise_date":"2021-12-16","underlying":"Common Stock","underlying_shares":26087},"source":{"system":"sec-edgar","filing":"0001683168-20-004322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/836564/000168316820004322/ownership.xml","form_type":"4"}},{"id":4223047,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":144629,"kind":"person","name":"JOHNSON CARLTON M","position":1,"cik":"0001244103","reported_name":"JOHNSON CARLTON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-08-29T17:15:39.000Z","date":"2017-08-25","kind":"other","acquired":false,"shares":14934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the settlement terms of a derivative lawsuit approved by Vice Chancellor Laster by Order dated July 27, 2017 (the \"Settlement Date\"), Mr. Johnson has agreed to an annual compensation cap for a period of two years from the Settlement Date. Although not required, on August 25, 2017, Mr. Johnson voluntarily surrendered for cancelation and for no consideration, 20,024 options (originally granted on May 11, 2015) and 14,934 options (originally granted on June 2, 2016), which reduced his total annual compensation for fiscal years 2016 and 2017 to below the agreed upon cap."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying option grant provided for vesting in eight (8) equal quarterly installments over a two (2) year period beginning September 2, 2016 and each quarter thereafter until fully-vested."}],"balance_after":239255,"derivative":{"exercise_price":3.5007,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":14934},"source":{"system":"sec-edgar","filing":"0001683168-17-002241","document":"johnson_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316817002241/johnson_frm4.xml","form_type":"4"}},{"id":4223046,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":144629,"kind":"person","name":"JOHNSON CARLTON M","position":1,"cik":"0001244103","reported_name":"JOHNSON CARLTON M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-08-29T17:15:39.000Z","date":"2017-08-25","kind":"other","acquired":false,"shares":20024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the settlement terms of a derivative lawsuit approved by Vice Chancellor Laster by Order dated July 27, 2017 (the \"Settlement Date\"), Mr. Johnson has agreed to an annual compensation cap for a period of two years from the Settlement Date. Although not required, on August 25, 2017, Mr. Johnson voluntarily surrendered for cancelation and for no consideration, 20,024 options (originally granted on May 11, 2015) and 14,934 options (originally granted on June 2, 2016), which reduced his total annual compensation for fiscal years 2016 and 2017 to below the agreed upon cap."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying option grant provided for vesting in eight (8) equal quarterly installments over a two (2) year period beginning August 11, 2015 and each quarter thereafter until fully-vested."}],"balance_after":254189,"derivative":{"exercise_price":9.17,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":20024},"source":{"system":"sec-edgar","filing":"0001683168-17-002241","document":"johnson_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316817002241/johnson_frm4.xml","form_type":"4"}}]}